Stansky Michael P 4

What Happened
Michael P. Stansky, a director of TriSalus Life Sciences, made two purchases on February 23, 2026: 243,900 shares at $4.10 each (≈ $999,990) and 117,198 shares at $4.10 each (≈ $480,512), for a combined 361,098 shares totaling about $1,480,502. These transactions are reported as purchases (code P), indicating acquisition rather than a sale.

Key Details

• Transaction date: 2026-02-23; Price: $4.10 per share.
• Shares purchased: 243,900 and 117,198 (total 361,098); Total value ≈ $1,480,502.
• Shares owned after transaction: Not specified in the portion of the filing provided.
• Footnote: Shares were purchased by Skyview Investments LLC. Mr. Stansky is the managing member and may be deemed to beneficially own these securities; voting and dispositive power over Skyview’s holdings is exercised by him as managing member.
• Filing timeliness: Reported on 2026-02-23 (same day), so not indicated as late.

Context
These were purchases by an entity (Skyview Investments LLC) controlled by the director, so the filing reports beneficial ownership through that entity. Purchases by insiders or their controlled entities are often of interest to investors as one piece of information about insider conviction, but they do not guarantee future company performance.